When Do You Start Seeing Weight Loss on Wegovy

The decision most people face: early patience versus giving up too soon

There is a mismatch between what people expect from Wegovy and what the medicine actually does in the early weeks. Semaglutide reduces appetite by acting on GLP-1 receptors in the brain and gut, slowing gastric emptying so that fullness arrives sooner and lingers longer. That effect begins from the first dose. What does not begin immediately is significant fat loss, and conflating the two is where a lot of people lose confidence and stop prematurely.

The starter dose of 0.25 mg exists almost entirely for tolerability. Your body is meeting a new mechanism; the first four weeks are about minimising nausea, not about the number on the scales. When people ask when they should start seeing results from Wegovy, the honest answer is that the question has two parts: when does appetite shift, and when does that translate to measurable weight change. The first can happen within days. The second, in a clinically significant sense, typically takes six to twelve weeks at minimum.

One practical habit worth building: weigh yourself on the same day each week, same time, same conditions, and record it. A single weekly snapshot removes the noise of daily fluid fluctuation and gives you a fairer read on what the medicine is doing over time. A four-week trend tells you far more than a Tuesday morning after a salty meal.

What the trial evidence says about when weight loss becomes visible

The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults over 68 weeks using 2.4 mg semaglutide alongside lifestyle support. Average body-weight reduction was around 15%, roughly 15 kg for a person starting at 100 kg. That figure is from the maintenance dose after a full titration sequence, not from week two on 0.25 mg. The trial's weight-loss curves show most of the measurable loss accumulating between weeks four and about week fifty, with the sharpest rate of change in the mid-dose period.

For most people starting Wegovy, if you are wondering when you actually see weight loss on Wegovy, the first noticeable scale movement typically arrives somewhere in weeks four to eight, aligning with reaching 0.5 mg or 1.0 mg on the titration schedule. Clothing fit often registers before the scale does, because body composition changes can precede the headline number. People who report seeing very little change on the starter dose are not experiencing treatment failure, they are experiencing the starter dose working as designed.

The six-month checkpoint matters. NICE's appraisal of semaglutide for weight management (TA875) includes a clinical stopping rule: if fewer than 5% of starting body weight has been lost after six months on the maintenance dose, continuing should be reviewed. That threshold is about the maintenance dose, not the dose you start on.

What affects how quickly you personally see results

The 15% trial average is a population mean, not a prediction for any individual. Several factors shape where you land on that distribution and how quickly weight loss becomes visible.

Dose progression is the most direct lever. Titration typically moves in four-week steps, but if side effects are pronounced, a prescriber may hold a dose for longer, which is clinically correct but extends the timeline to the dose where most weight loss occurs. Starting weight also matters: a larger absolute loss in kilograms can reflect the same percentage change as a smaller absolute loss for a lighter person, which affects when the change feels noticeable. Sleep quality, stress, and whether you are making practical dietary changes alongside treatment all influence how the medicine's appetite-reduction effect translates to actual calorie reduction in daily life.

Underlying health conditions interact too. Hypothyroidism managed poorly, certain medications, and hormonal factors can all blunt or delay the response. None of this means the medicine is not working, it means the picture is more nuanced than a single expected week number suggests. If you are six to eight weeks in and feel genuinely uncertain about your response, that is worth discussing with your prescriber rather than drawing conclusions alone. You can read about how long Wegovy takes to work across different people for a broader look at this variation.

Exploring the full range of weight-loss treatment options alongside lifestyle changes is worth doing before or during treatment, Wegovy works best as part of a sustained approach, not as a standalone fix.

When slow progress is worth investigating, and what comes next

Slow early progress is normal. Persistent lack of any progress at a therapeutic dose is a different matter. If you reach 2.4 mg, the standard maintenance dose, and twelve weeks pass without measurable change, your prescriber needs to know. It may prompt a conversation about adherence, injection technique, concurrent medicines, or whether semaglutide is the right choice for you specifically.

The NHS medicines page for semaglutide provides a reliable reference for what to expect from the medicine and when to seek advice. The Patient Information Leaflet that comes with your pen is also specific to the product you are using and should be your first read before and after each dose change.

At the six-month mark, a review with your prescriber is appropriate regardless of result. For people who are progressing well, that review considers whether to continue; for people who have not reached the 5% threshold, it considers what next. That is not a failure point, it is the clinical process working as it should.

If you are considering starting Wegovy through a private pharmacy, understanding what is included in the cost of treatment is a reasonable first step before deciding. And if you would like a prescriber to look at your individual picture, starting a free consultation is how that conversation begins at nume.